News

Displaying 1 - 20 of 36

EU drugs agency announces Scientific Committee line-up for next three years

20.12.2013

On 5 December, the EMCDDA Management Board appointed 15 high-level scientists to serve on the agency’s Scientific Committee for the period 2014–16. The selection followed a call for expressions of interest in the Official Journal of the European Union in February this year which yielded 79 eligible...

EMCDDA launches first four studies in a new series targeting policymakers and specialists

12.12.2013

The EU drugs agency (EMCDDA) publishes today the first four studies in its brand new series of ‘EMCDDA Papers’. Primarily targeting policymakers and specialists, the papers are designed as brief and timely web-based products on a variety of topics in the drugs field. To be published several times a...

EMCDDA launches new toolkit for monitoring infectious diseases among people who inject drugs

29.11.2013

Ahead of World AIDS Day on 1 December, the EU drugs agency (EMCDDA) has released today a new toolkit offering countries the latest guidance on monitoring infectious diseases, such as HIV/AIDS and viral hepatitis (B,C), among people who inject drugs (PWID) (1). The toolkit is designed to help health...

EMCDDA hosts workshop on evidence sharing to prevent and reduce harm related to addiction

25.11.2013

Sharing evidence to help prevent and reduce harm related to addiction is the focus of a workshop hosted by the EU drugs agency (EMCDDA) in Lisbon this week. The two-day event, opening today, is organised by the European Agency for Health and Consumers (EACH) (1), in collaboration with the European...

Europe takes decisive step forward in monitoring drug supply

15.11.2013

A set of Council conclusions on improving the monitoring of drug supply in the European Union was adopted by the Economic and Financial Affairs Council meeting in Brussels today (1). While much progress has been made in the EU in recent years to improve the monitoring of drug demand, drug supply...

CICAD–OAS Executive Secretary, Ambassador Paul E. Simons, visits EMCDDA to discuss cooperation and perspectives for work programme 2014–18

06.11.2013

  Ambassador Paul E. Simons, Executive Secretary of the Inter-American Drug Abuse Control Commission (CICAD) of the Organization of American States (OAS) visits the EMCDDA today to discuss with the agency’s Director Wolfgang Götz perspectives for the next EMCDDA–CICAD work programme (2014–18)....

2013 EMCDDA scientific paper award applauds excellence in drug-related research

06.11.2013

The four winners of the 2013 EMCDDA scientific paper award will be honoured in Lisbon this week at the third annual award ceremony hosted by the EU agency (1). The winners — based in Germany, Austria, Norway and at the EMCDDA — will receive a non-monetary prize for their contributions on 7 November...

Wound botulism among people who inject heroin in Norway – joint ECDC/EMCDDA rapid risk assessment

31.10.2013

As of 28 October 2013, six cases of wound botulism have been reported in Norway among people who had injected heroin. Two cases have been confirmed through mice inoculation and four are suspected cases with laboratory results pending.  All cases reported heroin use and most reported intramuscular...

EMCDDA: 20 years

30.10.2013

It is 20 years today since the EMCDDA’s founding regulation, Council Regulation (EEC) Nº 302/93, came into effect. On 29 October 1993, the Heads of State decided that the seat of the EMCDDA would be Lisbon and the regulation entered into force the following day. Over these years, the agency has...

EMCDDA publications recognised by the American Library Association

30.10.2013

Three of the EMCDDA’s publications have recently been recognised among the ‘notable government documents 2012’ by the American Library Association (ALA). The three publications are: the EU drug markets report: a strategic analysis; Cannabis production and markets and New heroin-assisted treatment:...

Reitox Academy: Preventing and controlling infectious diseases among people who inject drugs

29.10.2013

Preventing and controlling infectious diseases among people who inject drugs is the focus of the latest EMCDDA Reitox Academy opening today in Sarajevo (Bosnia and Herzegovina). The two-day event gathers over 20 experts from five candidate and potential candidate countries to the EU (1). Building...

EMCDDA Director opens workshop showcasing Croatia’s national drug monitoring system

22.10.2013

EMCDDA Director Wolfgang Götz will be opening a workshop today in Zadar, Croatia, in his first official visit to the country since its accession to the EU in July 2013. The two-day workshop, which focuses on Croatia’s national drug monitoring system, is being organised by the European Commission’s...

EMCDDA supports national drug observatories via training on contemporary approaches to drug monitoring

30.09.2013

‘Analysing, interpreting and disseminating drug-related data to facilitate decision-making’ will be the focus of an innovative training course hosted by the EU drugs agency (EMCDDA) this week in Lisbon. Opening today and running until 2 October, the event is a thematic twinning initiative of the EU...

New-style EMCDDA expert meetings promote integrated approach to monitoring

23.09.2013

The first EMCDDA week on ‘Measuring, understanding and responding to drug problems in Europe’ opens today in Lisbon, gathering experts from across the European Union, as well as the Russian Federation, South Africa, the United States and international organisations. The initiative represents a new...

EMCDDA welcomes European Commission call for stronger EU action on new drugs

17.09.2013

The EU drugs agency (EMCDDA) welcomes the European Commission's proposal today to strengthen the EU’s response to new psychoactive substances (‘new drugs’)(1). The proposal follows an unprecedented rise in the number of new drugs detected in Europe in recent years and a Commission review of the EU’...

Experts to examine latest scientific research in the field of new drugs

12.09.2013

Novel (or new) psychoactive substances (NPS) are an ever-increasing group of synthetic, semi-synthetic or natural compounds, often advertised and sold as ‘legal’ alternatives to illicit drugs. Often misrepresented as ‘safe’ for recreational use, they can, however, prove as harmful as controlled...

European Parliament LIBE Committee members on fact-finding visit to EMCDDA

16.07.2013

Members of the European Parliament Committee on Civil Liberties, Justice and Home Affairs (LIBE) will visit the EU drugs agency (EMCDDA) on 18 and 19 July where they will meet Director Wolfgang Götz and staff and hear why a sound evidence base is essential for effective policymaking and action in...

Speech by Wolfgang Götz, EMCDDA Director at the Third international multi-disciplinary forum on new drugs

27.06.2013

It is a great pleasure for me to welcome you to the Third international multidisciplinary forum on new drugs. I am really glad to see such an impressive audience of European and international participants. This forum — which has been organised by the EU drugs agency (EMCDDA), in cooperation with...

New EMCDDA report reveals how a better understanding of the science of ‘addiction’ can improve our response to drug problems

26.06.2013

Addiction is a global issue that costs many millions of lives each year and causes untold suffering. In a new report, released today to mark International day against drug abuse and illicit trafficking, the EU drugs agency (EMCDDA) looks at how far the science of addiction has come and how this...

Speech by Wolfgang Götz, EMCDDA Director

26.06.2013

Dear Ambassadors and members of the Lisbon diplomatic community Dear Representatives of the Portuguese authorities Ladies and gentlemen, dear colleagues and friends It is my great pleasure to welcome you today, together with the Chairman of the EMCDDA Management Board Dr João Goulão, to this...
Loading